Financials
- Market Capitalization 41.26 M
- Employee 20
- Founded 1971
- CEO N/A
- Website www.verupharma.com
- Headquarter Wisconsin, United States
- FIGI BBG000G12J78
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.45
Relación precio/flujo de caja
12.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4227 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | +2.25% | -5.21% | -49.72% | 44.23 M USD | ||
| 4239 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.04 USD | -2.86% | 0.00% | -8.93% | -48.74% | 42.91 M USD | ||
| 4258 | LNAI Lunai Bioworks Inc. - Common Stock | 1.12 USD | +2.75% | -23.29% | -56.42% | -8.20% | 40.62 M USD | ||
| 4285 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 0.99 USD | +1.02% | -9.17% | -13.91% | -31.25% | 37.40 M USD |